McKesson Corporation (NYSE:MCK) Shares Will Pay Quarterly Dividend of $0.94

McKesson Corporation (NYSE:MCK) declared a quarterly dividend on Tuesday, October 20th. Investors of record on Tuesday, December 1st will be paid a dividend of $0.94 per share on Monday, January 4th. This represents a $3.76 annualized dividend and a yield of 0.4%. The ex-dividend date is Tuesday, December 1st.

McKesson has raised its dividend by an average of 0.1% per year over the last three years and has increased its dividend every year for the last 17 years. McKesson has a payout ratio of 9.0% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect McKesson to earn $49.99 per share next year, which means the company should continue to be able to cover its $3.76 annual dividend with an expected future payout ratio of 7.5%.

McKesson Stock Performance

NYSE:MCK traded down $15.33 during trading hours on Wednesday, reaching $1,014.79. The company’s stock had a trading volume of 772,054 shares, compared to its average volume of 928,098. The stock has a 50 day moving average price of $902.90 and a two-hundred day moving average price of $839.47. The company has a market capitalization of $118.31 billion, a P/E ratio of 27.16, a price-to-earnings-growth ratio of 2.01 and a beta of 0.30. McKesson has a 12 month low of $723.68 and a 12 month high of $1,030.27.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The business had revenue of $105.38 billion for the quarter, compared to analysts’ expectations of $103.88 billion. During the same quarter last year, the firm earned $8.26 EPS. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, analysts predict that McKesson will post 44.71 EPS for the current fiscal year.

Key Headlines Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: UBS raised its price target to $1,200, while Mizuho lifted its target to $1,020 from $905. The revisions reflect continued confidence in McKesson’s earnings outlook, although Mizuho maintained a neutral rating and its target implies limited additional upside. UBS raises McKesson price target
• Positive Sentiment: McKesson declared its regular quarterly dividend of $0.94 per share, payable January 4, 2027, supporting the shareholder-return case. McKesson declares quarterly dividend
• Positive Sentiment: The company’s latest results exceeded expectations, with adjusted earnings of $9.93 per share and revenue of $105.38 billion, up 7.7% year over year. Fiscal 2027 EPS guidance remains $44.20-$45.00, helping support the recent analyst optimism.
• Neutral Sentiment: McKesson recently reached a new one-year high following analyst upgrades, while elevated search interest has brought additional attention to the stock. However, the shares’ strong advance leaves investors focused on whether further earnings growth can justify the valuation. McKesson hits new one-year high
• Negative Sentiment: An article concerning a McKesson security incident highlights potential enterprise cybersecurity, operational and reputational risks. The report does not establish a material financial impact, but it may be contributing to investor caution. McKesson security incident analysis
• Negative Sentiment: Executive Vice President Francisco Fraga sold 800 shares worth approximately $796,640. The transaction was made under a pre-arranged Rule 10b5-1 plan, reducing its signaling value, but it can still add to short-term profit-taking pressure. McKesson executive share sale

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.